Entyvio Injection, Powder, Lyophilized, For Solution
Product Images NDC 64764-300

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Entyvio (NDC 64764-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Entyvio 01

Label for ENTYVIO Pen injection, containing vedolizumab at 300 mg per vial strength. It is a single-dose vial for intravenous use only, requiring reconstitution and dilution before administration. The label includes dosage information, storage instructions, lot number, and expiration date fields. The labeler is Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Entyvio 02

Packaging label for Entyvio vedolizumab injection 300 mg per vial by Takeda Pharmaceuticals America, Inc. The label specifies the product is for intravenous use only, requires reconstitution and dilution prior to use, and is a single-dose vial. It includes storage instructions and a statement about receiving the enclosed medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.